AKT1 and neoplasm: Several tumor suppressors, such as p53, influence glucose metabolism in cancer cells by modulating the switch between glycolysis and OXPHOS, preventing the development of more aggressive tumor phenotypes via various pathways such as the PI3K-Akt pathways [104].